HOMEPAGE
Fully Diluted Subscribe

Nasdaq · Biotech stocks database

BGM — BGM Group Ltd.

BGM (BGM Group Ltd.) stock: $8.76, $117.0M market cap, $9.8M cash, $107.2M EV, $1.76B fully diluted market cap. Data from Fully Diluted's biotech stocks database.

What they do

BGM Group Ltd is a Cayman Islands holding company whose operations are conducted through its VIE, Gansu Qilianshan Pharmaceutical, in China. The company is engaged in the research, development, and production of licorice products, oxytetracycline products, traditional Chinese medicine derivatives, heparin products, sausage casings, and fertilizers.

Source: 20-F FY2025 via SEC EDGAR

Share price
$8.76
Market cap
$117.0M
Cash
$9.8M
Enterprise value
$107.2M

Balance sheet

Cash$9.8M
Debt$0.0M
Net cash$9.8M
Enterprise value$107.2M
Basic shares13.3M shares
Fully diluted shares200.9M shares
Fully diluted market cap$1,760.1M
Cash per share$0.74
Quarterly burn+$0.3M generated

Cash figures as of 2025-09-30. Database snapshot: 2026-11-07.

Share structure

Common
200.6M
Pre-funded warrants
0.0M
Options
0.0M
RSUs
0.0M
Warrants
0.3M
Converts
0.0M
Conv preferred
0.0M
ESPP reserve
—
FDSO
200.9M

Cap table as of 2025-09-30.

Price history

Loading BGM daily closes…

Loading price history…
Get the weekly biotech catalyst rundown.
Cash runways, financings, and trial readouts for all 721 stocks.
Subscribe to Compounding Ego